Physician profile
Michael S Webb
NPI 1881634996
$2,213.40
in general payments reported to CMS, 2019-2025
13 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $61.94 · 2021: $261 · 2022: $329 · 2023: $555 · 2024: $592 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $605.12 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $456.46 | 2023-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq, Intracept |
| Penumbra, INC. | $420.85 | 2023-2024 | Indigo System |
| Cook Medical LLC | $137.29 | 2019-2024 | Zilver Vena |
| Stryker Corporation | $133.24 | 2023 | Trevo, Target |
| Biocompatibles, INC. | $107.46 | 2019 | |
| Bard Peripheral Vascular, INC. | $100.07 | 2019-2024 | Fluency Endovascular Stent Graft |
| Ethicon US, LLC | $94.82 | 2023-2025 | Certus 140 |
| Medtronic, INC. | $46.35 | 2022 | |
| Terumo Medical Corporation | $43.00 | 2023 | Angio-Seal, Navicross, Glidesheath Slender |
| W. L. Gore & Associates, INC. | $34.31 | 2019 | |
| Gilead Sciences, INC. | $19.05 | 2025 | |
| Shockwave Medical, INC | $15.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.